Company Filing History:
Years Active: 1985-1988
Title: Innovations of Lawrence D Tobias
Introduction
Lawrence D Tobias is a notable inventor based in Glen Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thromboxane synthase inhibitors. With a total of 3 patents, his work focuses on innovative solutions for insulin regulation and obesity management.
Latest Patents
Tobias's latest patents include groundbreaking research on thromboxane synthase inhibitors as insulin-lowering agents. These compounds are categorized into various classes, such as 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids. His work also emphasizes the use of these inhibitors as antiobesity agents, showcasing their potential in addressing metabolic disorders.
Career Highlights
Lawrence D Tobias is associated with Hoffmann-La Roche Inc., where he has been instrumental in advancing research in his field. His innovative approaches have led to significant advancements in therapeutic options for patients dealing with insulin resistance and obesity.
Collaborations
Throughout his career, Tobias has collaborated with esteemed colleagues, including James Guthrie Hamilton and Ann C Sullivan. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.
Conclusion
Lawrence D Tobias's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to innovation in healthcare. His work continues to pave the way for new treatments that can improve the quality of life for many individuals.